Cargando…

From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?

Detalles Bibliográficos
Autor principal:	Raj, Gerard Marshall
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176695/ https://www.ncbi.nlm.nih.gov/pubmed/30319951 http://dx.doi.org/10.4103/picr.PICR_102_18

Ejemplares similares

“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”
por: Gabble, Ravinder, et al.
Publicado: (2014)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation
por: Nieves, Delma, et al.
Publicado: (2018)

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
por: Waye, Arianna, et al.
Publicado: (2015)

Rapid kinetics of serum IgA after vaccination with Prevnar(®)13 followed by Pneumovax(®)23
por: Crowther, Rebecca R., et al.
Publicado: (2017)

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
por: Buchwald, Ulrike K., et al.
Publicado: (2021)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)

In response to Nobel prize in physiology or medicine by the Indian medical education system: How far and how close?
por: Panigrahi, Sunil K., et al.
Publicado: (2023)

Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
por: Scotet, Julie, et al.
Publicado: (2011)

Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
por: Szczepanek, Steven M., et al.
Publicado: (2016)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

Double Intussuscepted Patent Vitellointestinal Duct
por: Basu, Syamantak, et al.
Publicado: (2021)

Video Directly Observed Treatment: How Effective Will it be in Indian Setting?
por: Majumdar, Anindo, et al.
Publicado: (2015)

Patent Foramen Ovale and Migraine: Casual or Causal
por: Hajra, Adrija, et al.
Publicado: (2016)

Patent Ductus Arteriosus Mimicking Hypertrophic Cardiomyopathy
por: Khajali, Zahra, et al.
Publicado: (2021)

Tuberculous and Non-Tuberculous Granulomatous Lymphadenitis in Patients Receiving Imatinib Mesylate (Glivec) for Metastatic Gastrointestinal Stromal Tumor
por: Agaimy, Abbas, et al.
Publicado: (2013)

Patent foramen ovale and stroke: Does presence of a migraine headache or any character of patent foramen ovale increase the risk of stroke?
por: Shariat, Abdolhamid, et al.
Publicado: (2015)

Response to the comments on impact on bronchial asthma in Indian population
por: Ramasamy, Anandha K, et al.
Publicado: (2015)

Bregmatic dermoid cyst in a patent anterior fontanelle
por: Dadlani, Ravi, et al.
Publicado: (2013)

Patent ductus arteriosus ligation: Do not take it easy
por: Vijayakanthi, Bhuvana, et al.
Publicado: (2013)

Patent vitellointestinal duct with ileal prolapse in a newborn
por: Roy, Dipankar, et al.
Publicado: (2015)

Indian perspective of remdesivir: A promising COVID-19 drug
por: Singh, Devendra, et al.
Publicado: (2020)

Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
por: Reilley, Brigg, et al.
Publicado: (2019)

Management of Skin Toxicity Related to the Use of Imatinib Mesylate (STI571, Glivec™) for Advanced Stage Gastrointestinal Stromal Tumours
por: Scott, Lucy C., et al.
Publicado: (2005)

Cost-effectiveness analysis of devices for closure of patent ductus arteriosus
por: Krishnamoorthy, KM, et al.
Publicado: (2018)

Response to ‘pervasive sequence patents cover the entire human genome’
por: Tu, Shine, et al.
Publicado: (2014)

Analysis of patents targeting antimetastatic effect using herbal materials
por: Kim, Sul-Ki, et al.
Publicado: (2020)

Guidewire Passage into the Left Atrium through the Patent Foramen Ovale
por: Taisuke, Kumamoto, et al.
Publicado: (2023)

Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence?
por: Gonçalves-Pereira, João, et al.
Publicado: (2011)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

How does KDQoL-36 questionnaire predict quality of life in Indian hemodialysis patients?
por: Rostami, Z., et al.
Publicado: (2012)

American Indian and Hispanic Populations Have Cultural Values and Issues Similar to Those of Appalachian Populations
por: Marshall, Catherine A
Publicado: (2007)

How to Create Memorizable and Strong Passwords
por: Cipresso, Pietro, et al.
Publicado: (2012)

Heart Valve Surgery in Patients with Patent Coronary Artery Bypass Grafts
por: Misawa, Yoshio, et al.
Publicado: (2018)

Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi Syndrome
por: Aghaei-Moghadam, Ehsan, et al.
Publicado: (2013)

Kinking of a patent flexometallic tube due to dislodgement of reinforcing spirals
por: Dube, Surya Kumar, et al.
Publicado: (2013)

Anesthetic management of a patient with hypertrophic cardiomyopathy and patent ductus arteriosus
por: Jung, Hoon, et al.
Publicado: (2013)

Anesthesia Challenges in Patent Ductus Arteriosus Stenting for Congenital Heart Disease
por: Nanditha, S, et al.
Publicado: (2017)

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
por: Gemelli, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hpvfdnj1s6cleepbg2bnank3t8